Laure Gossec

2004–2026 年に発表

225
論文数
38,179
被引用数
95
h 指数
209
i10 指数

被引用数

Laure Gossec の年別被引用数1986 年: 被引用 1 件1988 年: 被引用 1 件1998 年: 被引用 1 件2000 年: 被引用 1 件2004 年: 被引用 1 件2005 年: 被引用 6 件2006 年: 被引用 10 件2007 年: 被引用 15 件2008 年: 被引用 31 件2009 年: 被引用 55 件2010 年: 被引用 74 件2011 年: 被引用 132 件2012 年: 被引用 131 件2013 年: 被引用 144 件2014 年: 被引用 234 件2015 年: 被引用 278 件2016 年: 被引用 276 件2017 年: 被引用 289 件2018 年: 被引用 272 件2019 年: 被引用 1,138 件2020 年: 被引用 1,563 件2021 年: 被引用 1,739 件2022 年: 被引用 1,310 件2023 年: 被引用 719 件2024 年: 被引用 1,182 件2025 年: 被引用 409 件2026 年: 被引用 11 件1987 年は被引用が無いため表示していません1989〜1997 年は被引用が無いため表示していません1999 年は被引用が無いため表示していません2001〜2003 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,100 件、この内訳の 14%イギリス: 引用元論文 1,438 件、この内訳の 9.6%イタリア: 引用元論文 850 件、この内訳の 5.6%フランス: 引用元論文 844 件、この内訳の 5.6%ドイツ: 引用元論文 838 件、この内訳の 5.6%オランダ: 引用元論文 812 件、この内訳の 5.4%カナダ: 引用元論文 724 件、この内訳の 4.8%中国: 引用元論文 566 件、この内訳の 3.7%スペイン: 引用元論文 553 件、この内訳の 3.7%オーストラリア: 引用元論文 448 件、この内訳の 3%スイス: 引用元論文 404 件、この内訳の 2.7%日本: 引用元論文 402 件、この内訳の 2.7%
0%14%その他 33.6%

分野

  • Medicine83.3%
  • Immunology and Microbiology6%
  • Biochemistry, Genetics and Molecular Biology4%
  • Health Professions2%
  • Social Sciences1.4%
  • Psychology0.6%
  • その他2.7%

トピック

  • Rheumatoid Arthritis Research and Therapies17.9%
  • Spondyloarthritis Studies and Treatments10.3%
  • Autoimmune and Inflammatory Disorders Research5.5%
  • Psoriasis: Treatment and Pathogenesis4.7%
  • Systemic Lupus Erythematosus Research3.6%
  • COVID-19 Clinical Research Studies2.4%
  • その他55.6%

共著者

全論文

検索で開く
  1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain B. McInnes, Eduardo Mysler, Peter Nash, Karel Pavelká, Gyula Poór, Christophe Richez, Piet L. C. M. van Riel, Andrea Rubbert‐Roth, Kenneth G. Saag, José António Pereira da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée van der Heijde - Annals of the Rheumatic Diseases 2017 被引用: 5,775

  2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , T. Huizinga, Marios Koloumas, Zhanguo Li, Xavier Mariette, Ulf Müller‐Ladner, Eduardo Mysler, José António Pereira da Silva, Gyula Poór, Janet Pope, Andrea Rubbert‐Roth, Adeline Ruyssen‐Witrand, Kenneth G. Saag, Anja Strangfeld, Tsutomu Takeuchi, Marieke Voshaar, René Westhovens, Désirée van der Heijde - Annals of the Rheumatic Diseases 2020 被引用: 2,766

  3. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2020 被引用: 948

  4. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yoshiya Tanaka, Filip Van den Bosch, Annette H M van der Helm–van Mil, Alen Zabotti, Désirée van der Heijde, Josef S Smolen - Annals of the Rheumatic Diseases 2024 被引用: 331

  5. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher T. Ritchlin, Martín Rudwaleit, Adrian Tanew, Bing Thio, Douglas J. Veale, Kurt de Vlam, Désirée van der Heijde - Annals of the Rheumatic Diseases 2017 被引用: 676

  6. Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)

    著者: , , , , , , , , , , , , , , , , , , - The Lancet 2022 被引用: 158

  7. EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2023 被引用: 116

  8. Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)

    著者: , , , , , , , , , , , , , , , - The Lancet 2022 被引用: 157

  9. Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0

    著者: , , , , , , , , , , , , , , - Journal of Clinical Epidemiology 2014 被引用: 784

  10. The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review

    著者: , , , , , - Journal of Clinical Medicine 2021 被引用: 109

  11. Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial

    著者: , , , , , , , , , , - Annals of the Rheumatic Diseases 2020 被引用: 188

  12. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zara Izadi, Lindsay Jacobsohn, Patricia Katz, Lianne Kearsley‐Fleet, Philip C. Robinson, Jinoos Yazdany, Pedro Machado - Annals of the Rheumatic Diseases 2021 被引用: 691

  13. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2014 被引用: 421

  14. EULAR recommendations for patient education for people with inflammatory arthritis

    著者: , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2015 被引用: 399

  15. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

    著者: , , , , , , , , - Annals of the Rheumatic Diseases 2014 被引用: 711

  16. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2016 被引用: 272

  17. Detection of Flares by Decrease in Physical Activity, Collected Using Wearable Activity Trackers in Rheumatoid Arthritis or Axial Spondyloarthritis: An Application of Machine Learning Analyses in Rheumatology

    著者: , , , , , , , , , , , , , - Arthritis Care & Research 2018 被引用: 151

  18. Characterisation of prodromal and very early psoriatic arthritis: a systematic literature review informing a EULAR taskforce

    著者: , , , , , , , , , - RMD Open 2023 被引用: 36

  19. Quality of life in psoriatic arthritis

    著者: , - Expert Review of Clinical Immunology 2018 被引用: 193

  20. Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS)

    著者: , , , , , , , , , - Annals of the Rheumatic Diseases 2021 被引用: 103

  21. Mortality in rheumatoid arthritis over the last fifty years: Systematic review and meta-analysis

    著者: , , , , , , - Joint Bone Spine 2012 被引用: 291

  22. Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology

    著者: , , , , , , , , , , , , , , , - The Journal of Rheumatology 2019 被引用: 100

  23. Remission and low disease activity in psoriatic arthritis publications: a systematic literature review with meta-analysis

    著者: , , , , , - Lara D. Veeken 2020 被引用: 62

  24. European League Against Rheumatism recommendations for the inclusion of patient representatives in scientific projects

    著者: , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2011 被引用: 314